Andrew A. F. Hack, Director at Mersana Therapeutics, Inc. (MRSN), bought 4,091,334 shares at $7.74 ($25.6M) on 2020-04-07, disclosed to the SEC on 2020-04-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.59 | 2,800,000 | $15.7M | 61.0% |
| 2 | $7.74 | 645,667 | $5.0M | 19.5% |
| 3 | $7.74 | 645,667 | $5.0M | 19.5% |
| Total | $6.27 avg | 4,091,334 | $25.6M | 100% |
| Filing → |
| DVAX | SELL | 2023-08-10 | $21.6M | — | Filing → |
| DVAX | SELL | 2023-06-16 | $6.3M | — | Filing → |
| DVAX | SELL | 2023-05-19 | $10.6M | — | Filing → |